Mayne And Mithra Obtain Long-Awaited NuvaRing Nod From FDA

Haloette Will Be One Of Three Generics In US Market, Alongside Amneal And Teva

 
• By Dave Wallace

Following a trio of complete response letters received since late 2018, Mayne Pharma and partner Mithra Pharmaceuticals have finally obtained US FDA approval for a generic version of Organon’s NuvaRing vaginal hormonal contraceptive ring.

Hands one two three fingers red blue yellow 1 2 3
After receiving three CRLs, Mayne and Mithra now have the chance to market one of three Nuvaring generics in the US • Source: Shutterstock

More from Products

More from Generics Bulletin